main-logo

ICD-10 Code B48.2 | Allescheriasis Symptoms, Diagnosis, Billing

Allescheriasis is a rare infection caused by the fungus Allescheria boydii, primarily affecting immunocompromised individuals. It can lead to severe pulmonary and systemic complications. Accurate coding with ICD-10 Code B48.2 is essential for proper diagnosis, documentation, medical billing, and public health reporting, ensuring that healthcare providers can track and manage this condition effectively.

What is ICD-10 Code B48.2 for Allescheriasis?

ICD-10 Code B48.2 represents Allescheriasis, an opportunistic fungal infection associated with immunosuppression. This code should be used when documenting cases of Allescheriasis in clinical settings, particularly when patients present with respiratory symptoms or systemic illness related to this infection, ensuring accurate billing and compliance with healthcare regulations.

ICD-10 Code B48.2 – Clinical Definition and Explanation of Allescheriasis

Allescheriasis is caused by the fungus Allescheria boydii, which typically affects individuals with weakened immune systems. The condition can progress rapidly, leading to significant morbidity and necessitating prompt medical intervention. Early recognition and treatment are crucial to prevent severe complications.

Key Clinical Features:

  • Immunocompromised status (e.g., HIV, cancer treatment)
  • Respiratory symptoms such as cough and dyspnea
  • Fever and systemic signs of infection
  • Possible pulmonary nodules or infiltrates on imaging

ICD-10 Code B48.2 for Allescheriasis – SOAP Notes & Clinical Use

In SOAP notes, ICD-10 Code B48.2 is utilized to document the diagnosis of Allescheriasis, aiding in the assessment of symptoms, clinical findings, and treatment plans. This code is relevant in both acute and chronic care settings, ensuring comprehensive patient management.

What Does ICD-10 Code B48.2 for Allescheriasis Mean in SOAP Notes?

ICD-10 Code B48.2 connects subjective patient-reported symptoms and objective clinical findings to a formal diagnosis of Allescheriasis. This code is essential for ensuring continuity of care, supporting accurate billing, and meeting EHR documentation standards.

Treatment Options for ICD-10 Code B48.2 – Allescheriasis

Prompt treatment of Allescheriasis is critical, particularly in immunocompromised patients. Hospitalization may be necessary for severe cases.

Antibiotic Therapy:

  • Voriconazole (first-line) for 6-12 weeks
  • Amphotericin B (alternative) for severe cases
  • Fluconazole (alternative) for less severe cases
  • Consider combination therapy in resistant cases

Supportive Care:

  • Monitor vital signs and oxygen saturation
  • Provide supplemental oxygen if needed
  • Manage fever and pain with appropriate medications
  • Ensure hydration and nutritional support

Infection Control:

  • Implement standard precautions to prevent spread
  • Isolate patients with severe infections if necessary
  • Educate staff on fungal infection protocols
  • Monitor for outbreaks in healthcare settings

How to Document Symptoms of Allescheriasis (ICD-10 B48.2) in SOAP Notes

Subjective:

  • Patient reports persistent cough and shortness of breath
  • History of recent immunosuppressive therapy
  • Complaints of fever and fatigue
  • No known exposure to fungal sources

Objective:

  • Fever of 101°F on examination
  • Decreased breath sounds on auscultation
  • Chest X-ray shows infiltrates
  • Oxygen saturation at 92% on room air
card-topcard-bottom

Secure, compliant, and built for trust

HIPAA-compliant and designed with privacy in mind, your patient’s data is protected. Focus on care while we safeguard your information.

Learn more
hipaa-icon

SOAP Note Guidelines for Diagnosing Allescheriasis (ICD-10 Code B48.2)

Assessment:

  • Diagnosis: Allescheriasis, moderate severity
  • ICD-10 Code: B48.2
  • Contributing factors: Immunocompromised state
  • Consider differential diagnoses such as bacterial pneumonia

Plan:

  • Initiate voriconazole therapy
  • Educate patient on signs of worsening symptoms
  • Schedule follow-up chest imaging in 2 weeks
  • Monitor laboratory values for liver function and drug levels

Treatment & Plan Section for ICD-10 Code B48.2 – Allescheriasis

  • First-line treatment with voriconazole for fungal infection
  • Consider supportive care measures for respiratory distress
  • Regular monitoring of clinical status and laboratory parameters
  • Patient education on infection signs and follow-up care

Using ICD-10 Code B48.2 for Allescheriasis in Billing & SOAP Note Compliance

  • Ensure accurate documentation of symptoms and clinical findings
  • Use B48.2 in conjunction with relevant CPT codes for billing
  • Align treatment plans with clinical guidelines to support claims
  • Document all patient interactions and treatment decisions clearly

ICD-10 Code B48.2 in Medical Billing and Insurance for Allescheriasis

ICD-10 Code B48.2 is crucial for billing in hospital, ER, or infectious disease care settings.

Billing Notes:

  • Document all relevant clinical findings to support the diagnosis
  • Use B48.2 in appropriate clinical contexts for accurate billing
  • Ensure compliance with payer requirements for fungal infections
  • Include detailed treatment plans in medical records

Common CPT Pairings:

CPT CodeDescription
99223Initial hospital care, high complexity
36415Collection of venous blood by venipuncture
71046Radiologic examination, chest, 2 views
85025Complete blood count with differential

Frequently Asked Questions

Common Questions About Using ICD-10 Code B48.2 for Allescheriasis

What are the common symptoms of Allescheriasis?

Common symptoms include persistent cough, shortness of breath, fever, and fatigue, particularly in immunocompromised patients. Early recognition of these symptoms is crucial for timely intervention.

How is Allescheriasis diagnosed?

Diagnosis typically involves clinical evaluation, imaging studies such as chest X-rays, and microbiological testing to identify the presence of Allescheria boydii in respiratory specimens.

What is the treatment for Allescheriasis?

Treatment usually involves antifungal therapy, with voriconazole being the first-line option. Supportive care may also be necessary for managing respiratory symptoms and overall patient health.

Is Allescheriasis contagious?

Allescheriasis is not considered contagious; it primarily affects individuals with weakened immune systems. Infection control measures are important in healthcare settings to prevent outbreaks.

diamond-bg
diamond-bg

Get started with your 20 free notes

Sign up for free
main-logo

AI-aided Sudsy Shorthand for ink-free practices

support@soapsuds.io
hipaa-logo

Clinical Notes

SOAP notes

DAP notes

AI medical notes

© Copyright SOAPsuds 2025. All rights reserved